Diagnosticos da America (DASA)
DASA3.SA
#7475
Rank
C$0.41 B
Marketcap
$0.56
Share price
3.12%
Change (1 day)
-79.19%
Change (1 year)

P/E ratio for Diagnosticos da America (DASA) (DASA3.SA)

P/E ratio as of November 2024 (TTM): -1.62

According to Diagnosticos da America (DASA)'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.62377. At the end of 2022 the company had a P/E ratio of -19.8.

P/E ratio history for Diagnosticos da America (DASA) from 2009 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-19.8-76.26%
2021-83.4-64.11%
2020-232-265.25%
2019141209.84%
201845.4-28.6%
201763.69.82%
201657.9-55.36%
2015130209.33%
201441.921.97%
201334.4-32.77%
201251.153.95%
201133.2-43.15%
201058.4113.71%
200927.3

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.